Market Insights Snapshot
Heartland Holistics has maintained a steady performance in the Missouri market, particularly in the Topical category. For the months of July, August, September, and October 2023, the brand consistently held the second position in the ranking, indicating a strong presence and consumer preference in this category. While there was a slight dip in sales from July to September, a significant rebound was observed in October, pointing towards a positive trend in the brand's performance.
It's worth noting that the absence of a ranking number for a particular month would mean that the brand did not feature in the top 20 brands in that state and category for that month. However, in the case of Heartland Holistics, this was not an issue as the brand consistently ranked second in the Topical category in Missouri. This consistent performance, coupled with a strong sales trajectory, indicates that Heartland Holistics is a formidable player in the Missouri cannabis market.
In the Topical category within Missouri, Heartland Holistics has consistently maintained the second rank from July to October 2023, indicating a strong presence in the market. However, it's worth noting that the brand is significantly outperformed by Mary's Medicinals, which has consistently held the top spot in the same period. On the other hand, Heartland Holistics has consistently outperformed Escape Artists and Heartland Labs, which have fluctuated in rank over these months. Interestingly, despite its lower rank, Escape Artists showed a notable sales increase in October 2023, suggesting a potential future threat to Heartland Holistics' position. It's crucial for Heartland Holistics to continue monitoring these competitors and market trends to maintain its strong position.
In October 2023, Heartland Holistics saw the 'CBD/THC 3:4 High Dose Transdermal Patch (30mg CBD, 40mg THC)' reclaim its position as the top-selling product, with a notable sales figure of 1554 units. This product had slipped to second place in September but managed to regain its dominance. The 'FECO Transdermal Patch (50mg)' dropped to the second spot after outperforming in September. The 'CBD/THC/CBG 1:2:2 Morning Transdermal Patch (10mg CBD, 20mg THC, 20mg CBG)' maintained a steady third position throughout the four-month period. Lastly, the 'CBD/CBN/THC 1:1:1 Night Time Transdermal Patch (20mg CBD, 20mg CBN, 20mg THC)' remained at the fourth spot with no changes in its ranking.